COVID-19 antibody testing study: a nested substudy within Alberta’s Tomorrow Project (ATP) in Alberta, Canada
Serology results, together with health, lifestyle and sociodemographic data, and the continued follow-up of these participants as part of the broader ATP cohort study (planned through 2065), will provide opportunities to investigate the long-term sequelae of COVID-19 infection as well as the broader impacts of the pandemic on physical, mental and emotional health. Data are available to researchers on request through the ATP access process.
Authors
- Jennifer E. Vena (ORCID: https://orcid.org/0000-0002-6313-1126)
- K. Lines
- Graham Tipples (ORCID: https://orcid.org/0000-0002-2116-8553)
- Carmen L. Charlton (ORCID: https://orcid.org/0000-0002-9129-5136)
- James D. Kellner (ORCID: https://orcid.org/0000-0002-9083-2980)
- Jianyi Xu (ORCID: https://orcid.org/0000-0003-4552-8194)
- Jamil N. Kanji (ORCID: https://orcid.org/0000-0002-1043-6807)
- Wendy Powell (ORCID: https://orcid.org/0000-0002-7234-5628)
- Sara Nejatinamini (ORCID: https://orcid.org/0000-0003-0309-1238)
- Joseph Roberts
- Stephanie Harman (ORCID: https://orcid.org/0000-0002-7787-5855)
- Grace Shen-Tu
- Will Rosner
- Kathleen Murdoch
Institutions
- University of Alberta (CA)
- University of Calgary (CA)
- Alberta Hospital Edmonton (CA)
- Alberta Children's Hospital (CA)
- Alberta Cancer Foundation (CA)
- Canadian Blood Services (CA)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-101336
- Citations
- 1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Alberta Health Services
- Public Health Agency of Canada
- Government of Alberta
- Alberta Precision Laboratories
- Alberta Cancer Foundation
- Government of Canada
- Public Health Agency
- Partenariat Canadien Contre Le Cancer
- Health Canada
- Canadian Institutes of Health Research